Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry
Population
328 consecutive high-risk symptomatic patients with severe aortic stenosis evaluated by a heart team
Design
Cohort, non-randomized
Follow-up
1 year
Authors
Discussion
Loading...
Member takes
Implication
Acceptable real-world TAVI survival supports high-risk use; extends registries but leaves randomized device comparisons open.
Structured PICO
P
Population
328 consecutive high-risk symptomatic patients with severe aortic stenosis evaluated by a heart team
I
Intervention
Transcatheter aortic valve implantation (TAVI) using CoreValve (18 Fr transfemoral or subclavian) or Edwards Sapien valve (22 Fr transfemoral or 24 Fr transapical)
O
Outcome
Procedural success, 30-day survival, and one-year survivalhard clinical
TAVI using either CoreValve or Edwards Sapien systems in high-risk patients with severe aortic stenosis demonstrates high procedural success and acceptable one-year survival in a real-world national registry.
Cite This Study
Bosmans et al. (2011) studied this question.